中医药
肺炎
医学
病毒性肺炎
重症监护医学
2019年冠状病毒病(COVID-19)
计算生物学
生物
替代医学
传染病(医学专业)
疾病
内科学
病理
作者
Yi Bai,Tengwen Liu,Shuwen Zhang,Yifan Shi,Yumei Yang,Maoyu Ding,Xiaowei Yang,Shanshan Guo,Xiaolong Xu,Qingquan Liu
摘要
Different respiratory viruses might cause similar symptoms, ranging from mild upper respiratory tract involvement to severe respiratory distress, which can rapidly progress to septic shock, coagulation disorders, and multiorgan failure, ultimately leading to death. The COVID-19 pandemic has shown that predicting clinical outcomes can be challenging because of the complex interactions between the virus and the host. Traditional Chinese medicine (TCM) has distinct benefits in the treatment of respiratory viral illnesses due to its adherence to the principles of "different treatments for the same disease" and "same treatment for different diseases". This paper examines the effectiveness and underlying mechanisms of key TCM treatments for viral pneumonia in recent years. The aim of this study was to discover and confirm the active substances of TCM with potential therapeutic effects on viral pneumonia and their integrative effects and synergistic mechanisms and to provide a scientific basis for elucidating the effectiveness of TCM treatment and drug discovery. Furthermore, a thorough analysis of previous research is necessary to evaluate the effectiveness of TCM in treating viral pneumonia.
科研通智能强力驱动
Strongly Powered by AbleSci AI